The pharmacokinetics of oral cyclosporin A (neoral) during the first month after bone marrow transplantation

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 1668-1670

  Schultz, K R ^a   Nevill, T J ^b   Toze, C L ^b   Corr, T ^b   Currie, C ^b   Strong, D K ^b   Keown, P A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEWBORN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; METABOLIC CLEARANCE RATE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0031657646     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00385-6     Document Type: Conference Paper

References (8)

1. Kahan BD: Transplantation 40:457, 1986
2. Lindholm A, Henricsson S, Lind M, et al: Eur J Clin Pharmacol 34:46, 1988
3. Shaw LM, Bowers L, Demers L, et al: Clin Chem 33:1269, 1987
4. Sandimmune Neoral® product monograph, Sandoz Canada Inc., Quebec. January 11, 1995
5. Superina RA, Strong DK, Acal LA, DeLuca E: Transplant Proc 26:2979, 1994
6. McDonald GB, Shulman HM, Sullivan KM, et al: Gastroenterology 90:770, 1986
7. Atkinson K, Biggs JC, Britton R, et al: Br J Haematol 56:223, 1984
8. Yatscoff RW, Copeland KR, Faraci CJ: Clin Chem 36:1969, 1990